Current funding opportunities related to TB and HIV, expired RFAs will be hidden after closing date. Sort using the tags menu to the right.
For funding opportunities related to global health, please see the Vanderbilt Institute for Global Health announcements found here.
Burroughs Wellcome Fund: Investigators in the Pathogenesis of Infectious Disease (PATH), due annually in July
July 16, 2018 : Pre-proposal deadline
by Oct. 1, 2018 : Invitations sent
Nov. 15, 2018 : Full application deadline
The Investigators in the Pathogenesis of Infectious Disease (PATH) award provides $500,000 over five years to support accomplished investigators at the assistant professor level to study pathogenesis, with a focus on the interplay between human and microbial biology, shedding light on how human and microbial systems are affected by their encounters.
Webinars will be held June 14, 18, and 26.
Generating New Insights and Mechanistic Understanding of Antibiotic Resistance Development (R01/R21 Clinical Trial Not Allowed), expires: 05/08/2021
Application Due Date(s): Standard dates apply , by 5:00 PM local time of applicant organization.
The purpose of this Funding Opportunity Announcement (FOA) is to advance select areas of research recognized as critical in the National Action Plan for Combating Antibiotic-Resistant Bacteria (CARB), including research focused on understanding the nature of microbial communities, how antibiotics affect them, and how they can be harnessed to prevent disease, as well as research exploring combination therapies to address the emergence of resistance.
Ecology and Evolution of Infectious Diseases (EEID), due annually in November
Full Proposal Deadline Date: November 20, 2019
The Ecology and Evolution of Infectious Diseases program supports research on the ecological, evolutionary, and socio-ecological principles and processes that influence the transmission dynamics of infectious diseases. The central theme of submitted projects must be quantitative or computational understanding of pathogen transmission dynamics. The intent is discovery of principles of infectious disease transmission and testing mathematical or computational models that elucidate infectious disease systems. Projects should be broad, interdisciplinary efforts that go beyond the scope of typical studies. They should focus on the determinants and interactions of transmission among humans, non-human animals, and/or plants. This includes, for example, the spread of pathogens; the influence of environmental factors such as climate; the population dynamics and genetics of reservoir species or hosts; the cultural, social, behavioral, and economic dimensions of disease transmission. Research may be on zoonotic, environmentally-borne, vector-borne, or enteric diseases of either terrestrial or freshwater systems and organisms, including diseases of animals and plants, at any scale from specific pathogens to inclusive environmental systems. Proposals for research on disease systems of public health concern to developing countries are strongly encouraged, as are disease systems of concern in agricultural systems. Investigators are encouraged to develop the appropriate multidisciplinary team, including for example, modelers, bioinformaticians, genomics researchers, social scientists, economists, epidemiologists, entomologists, parasitologists, microbiologists, bacteriologists, virologists, pathologists or veterinarians, with the goal of integrating knowledge across disciplines to enhance our ability to predict and control infectious diseases.
https://www.nsf.gov/funding/pgm_summ.jsp?pims_id=5269
Notice of NIH Participation: https://grants.nih.gov/grants/guide/notice-files/NOT-TW-19-007.html
Bloomberg Initiative To Reduce Tobacco Use Grants Program
The Bloomberg Initiative to Reduce Tobacco use Grants Program utilizes World Bank country income groups to establish eligibility to apply for a grant. Organizations from low- and middle-income countries are welcome to apply. This includes low-income, lower-middle-income, and upper-middle-income countries.
Open Grant Round (OGR) – An international competitive grant round, open to applicants from any low or middle-income country. OGR applications should focus on a national policy gap in their country in the PWER areas of MPOWER, or FCTC Article 5.3 policy (this must be in association with strengthening MPOWER policies).
Strategic Grant Round (SGR) – This round is only open to applicants from the ten priority countries, and is focused on the priority issues identified for each of those countries.
The ten priority countries are:
- China
- India
- Indonesia
- Bangladesh
- Pakistan
- Vietnam
- Philippines
- Brazil
- Ukraine
- Mexico
NIMH Exploratory/Developmental Research Grant (R21 Clinical Trial Not Allowed), expires: 01/08/2021
Application Due Date(s): Standard dates apply , by 5:00 PM local time of applicant organization.
The NIMH Exploratory/Developmental Grant program supports exploratory and high-risk research projects that fall within the NIMH mission by providing support for the early and conceptual stages of these projects. These studies may involve considerable risk but may lead to a breakthrough or to the development of novel techniques, agents, methods, measures, models, or strategies, or to the generation of pilot or feasibility data. The preliminary work from these studies could lead to a major impact on biomedical, behavioral, or clinical mental health research, or on the delivery of mental health care.
Congressionally Directed Medical Research Programs (CDMRP), Department of Defense (DOD)
Application Due Date(s): Various times depending on research program.
Synopsis of Current Program Funding Opportunities
Dissemination and Implementation Research in Health (R01/R21 Clinical Trial Optional), expires: 05/08/2022
Application Due Date(s): Standard dates apply, by 5:00 PM local time of applicant organization.
This Funding Opportunity Announcement (FOA) encourages investigators to submit research grant applications that will identify, develop, test, evaluate and/or refine strategies to disseminate and implement evidence-based practices (e.g. behavioral interventions; prevention, early detection, diagnostic, treatment and disease management interventions; quality improvement programs) into public health, clinical practice, and community settings. In addition, studies to advance dissemination and implementation research methods and measures are encouraged.
R01: https://grants.nih.gov/grants/guide/pa-files/PAR-19-274.html
R21: https://grants.nih.gov/grants/guide/pa-files/par-19-275.html
R03: https://grants.nih.gov/grants/guide/pa-files/par-19-276.html
Emerging Global Leader Award (K43), expires: 11/05/2020
Application Due Date(s): November 7, 2019 and November 4, 2020 by 5:00 PM local time of applicant organization.
The purpose of the Fogarty Emerging Global Leader Award is to provide research support and protected time (three to five years) to an early career research scientist from a low- or middle-income country (LMIC) who holds a junior faculty position at an LMIC academic or research institution, as defined by the World Bank (http://data.worldbank.org/about/country-classifications/country-and-len…, including “low-income,” “lower-middle-income,” and “upper-middle-income” countries). This intensive, mentored research career development experience is expected to lead to an independently funded research career at the LMIC institution or in another LMIC. This Funding Opportunity Announcement (FOA) invites applications from LMIC scientists from any health-related discipline who propose career development activities and a research project that is relevant to the health priorities of their country under the mentorship of LMIC and U.S. mentors.
https://grants.nih.gov/grants/guide/pa-files/PAR-19-098.html
Global Infectious Disease Research Administration Development Award for Low-and Middle-Income Country Institutions (G11 Clinical Trial Not Allowed), expires: 07/29/2023
Application Due Date(s): July 28, 2021; July 28, 2022; July 28, 2023, by 5:00 PM local time of applicant organization.
The purpose of this Funding Opportunity Announcement (FOA) is to invite applications from research institutions in low- to middle-income countries (LMIC) to provide senior administrators from these institutions with advanced training in the management of NIH grants. The ultimate goal is to improve oversight of NIAID grant awards and compliance with NIH funding policies and Federal research funding requirements for NIAID-supported foreign institutions in low to middle-income countries.
https://grants.nih.gov/grants/guide/pa-files/PAR-21-037.html
HIV Prevention Trials Network (HPTN) Scholars Program (Domestic and International), due annually January
Application due:
- Initial proposal drafts for Domestic Scholars are due 5 January 2018 and full applications are due 19 January 2018
- Initial proposal drafts for International Scholars are due 29 January 2018 and full applications are due 12 February 2018
The HIV Prevention Trials Network (HPTN) is proud to offer two scholarship programs for early-career investigators funded through a supplement from the National Institute of Allergy and Infectious Diseases (NIAID) and the National Institute on Drug Abuse (NIDA). The HPTN Scholars Program now includes two components: a domestic (U.S.) program and an international program. Both programs seek to increase opportunities for scientists from groups under-represented in HIV prevention research. In the domestic program, successful applicants will be Investigators who have received their terminal degree (MD, Phd, etc). For the international version, current MD, PhD, and MBChB students may apply, along with individuals having already graduated with their terminal degree. In both programs, applicants should desire to work with a mentor scientist in the Network to complete a research project based upon an existing HPTN research study.